Raffaella Buzzetti

Pubblicazioni

Titolo Pubblicato in Anno
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study DIABETES THERAPY 2022
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus CARDIOVASCULAR DIABETOLOGY 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes DIABETES & METABOLISM 2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study ANTIOXIDANTS 2022
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA FRONTIERS IN ENDOCRINOLOGY 2022
Adult-onset autoimmune diabetes NATURE REVIEWS. DISEASE PRIMERS 2022
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY) ACTA DIABETOLOGICA 2022
Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2022
Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy MUSCLE & NERVE 2021
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study DIABETIC MEDICINE 2021
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS ACTA DIABETOLOGICA 2021
Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy MUSCLE & NERVE 2021
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism ENDOCRINE 2021
Small nerve fiber damage and Langerhans cells in type 1 and type 2 diabetes and LADA measured by corneal confocal microscopy INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 2021
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study DIABETES, OBESITY AND METABOLISM 2021
Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial NPJ DIGITAL MEDICINE 2021
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma